Clinical significance of chronic myocardial ischemia in coronary artery disease patients
- PMID: 31019790
- PMCID: PMC6462715
- DOI: 10.21037/jtd.2019.02.85
Clinical significance of chronic myocardial ischemia in coronary artery disease patients
Abstract
Myocardial ischemia is considered the cornerstone of the treatment of patients with coronary artery disease (CAD). Although the deleterious effects of myocardial infarction, the maximum expression of ischemia, have been extensively studied and described, the clinical effects of chronic, documented myocardial ischemia are not completely clarified. The first studies that compared therapies for coronary disease focused on the presence of anatomical features and assessed ischemia based on the interpretation of the findings of obstructive atherosclerotic lesions. They suggested that revascularization interventions did not confer any clinical advantage over medical therapy (MT), in terms of cardiac or overall death. Other retrospective studies that were dedicated to assessing the impact of documented stress-induced ischemia on cardiovascular outcomes have suggested a prognostic impact of chronic ischemia. However, this has been questioned in recent studies. Moreover, the previous understanding that chronic ischemia could lead to worsening of ventricular function was not confirmed in a recent study. Thus, the prognostic significance of stress-induced ischemia has been questioned. Regarding treatment options, although some previous analyses have suggested that interventional therapies would reduce cardiovascular events in CAD patients with documented ischemia, recent post-hoc studies and metanalysis have shown distinct results. In this review article, the authors discuss myocardial ischemia, the different responses of the myocardium to ischemic insults, ischemic preconditioning, and the main findings of recent studies about the clinical aspects and treatment of patients with chronic, documented myocardial ischemia.
Keywords: Myocardial infarction; atherosclerosis; ischemia; myocardium.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.JACC Cardiovasc Imaging. 2012 Jul;5(7):715-24. doi: 10.1016/j.jcmg.2012.01.019. JACC Cardiovasc Imaging. 2012. PMID: 22789940
-
Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?Am J Ther. 2004 Sep-Oct;11(5):366-411. doi: 10.1097/01.mjt.0000126444.24163.81. Am J Ther. 2004. PMID: 15356432 Review.
-
Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.JAMA Intern Med. 2014 Feb 1;174(2):232-40. doi: 10.1001/jamainternmed.2013.12855. JAMA Intern Med. 2014. PMID: 24296791 Review.
-
Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.JACC Cardiovasc Imaging. 2017 May;10(5):526-537. doi: 10.1016/j.jcmg.2017.02.006. Epub 2017 Apr 12. JACC Cardiovasc Imaging. 2017. PMID: 28412420
-
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.Am Heart J. 2018 Jul;201:124-135. doi: 10.1016/j.ahj.2018.04.011. Epub 2018 Apr 21. Am Heart J. 2018. PMID: 29778671 Free PMC article. Review.
Cited by
-
Functional compounds of ginseng and ginseng-containing medicine for treating cardiovascular diseases.Front Pharmacol. 2022 Dec 2;13:1034870. doi: 10.3389/fphar.2022.1034870. eCollection 2022. Front Pharmacol. 2022. PMID: 36532771 Free PMC article. Review.
-
Systematic Analysis of tRNA-Derived Small RNAs Discloses New Therapeutic Targets of Caloric Restriction in Myocardial Ischemic Rats.Front Cell Dev Biol. 2020 Nov 3;8:568116. doi: 10.3389/fcell.2020.568116. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33224944 Free PMC article.
-
A feasibility study of [18F]F-AraG positron emission tomography (PET) for cardiac imaging - myocardial viability in ischemia-reperfusion injury model.Res Sq [Preprint]. 2024 Apr 30:rs.3.rs-4244476. doi: 10.21203/rs.3.rs-4244476/v1. Res Sq. 2024. Update in: Mol Imaging Biol. 2024 Oct;26(5):869-878. doi: 10.1007/s11307-024-01932-y. PMID: 38746162 Free PMC article. Updated. Preprint.
-
A Feasibility Study of [18F]F-AraG Positron Emission Tomography (PET) for Cardiac Imaging-Myocardial Viability in Ischemia-Reperfusion Injury Model.Mol Imaging Biol. 2024 Oct;26(5):869-878. doi: 10.1007/s11307-024-01932-y. Epub 2024 Jul 26. Mol Imaging Biol. 2024. PMID: 39060882
-
Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.J Clin Med. 2021 Feb 12;10(4):721. doi: 10.3390/jcm10040721. J Clin Med. 2021. PMID: 33673114 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous